Emami Limited Announces Promoter Inter-se Share Transfer for February 26, 2026

2 min read     Updated on 17 Feb 2026, 03:11 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Emami Limited's promoter group has disclosed a proposed inter-se transfer of 21,58,936 shares representing 0.4946% of share capital, scheduled for execution on February 26, 2026. The transfer involves four transferor entities led by Ms. Avishi Sureka (14,00,000 shares) and ten acquirer entities, conducted as gifts without consideration under SEBI SAST regulations while maintaining the total promoter shareholding at 54.84%.

32866893

*this image is generated using AI for illustrative purposes only.

Emami Limited's promoter group has announced a proposed inter-se transfer of equity shares among promoter entities, scheduled to be executed on or after February 26, 2026. The disclosure was made under Regulation 10(5) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, with the announcement submitted to stock exchanges on February 17, 2026.

Proposed Transfer Details

The inter-se transfer involves multiple promoter entities as acquirers and transferors, with the transaction being conducted through off-market transfers by way of gift without any consideration. The aggregate shareholding of the promoter and promoter group will remain unchanged before and after the proposed transfer.

Transfer Parameter: Details
Total Shares to Transfer: 21,58,936 shares
Percentage of Share Capital: 0.4946%
Transaction Date: On and after February 26, 2026
Nature of Transaction: Gift without consideration
Market Price Reference: ₹512.96 per share (60-day VWAP)

Transferor and Acquirer Details

The proposed transfer involves four transferor entities and ten acquirer entities within the promoter group. The largest individual transfer involves Ms. Avishi Sureka transferring 14,00,000 shares, while the smallest involves Sri Radhe Shyam Goenka transferring 12,000 shares.

Share Transfer Breakdown

Transferor: Shares to Transfer: Acquirer Group:
Ms. Avishi Sureka: 14,00,000 Multiple promoter entities
Mr. Manan Goenka: 5,64,900 Multiple promoter entities
Smt Shruti Goenka: 1,82,036 Multiple promoter entities
Sri Radhe Shyam Goenka: 12,000 Multiple promoter entities

Current Shareholding Structure

The disclosure reveals the comprehensive shareholding pattern of the promoter group before and after the proposed transaction. Diwakar Finvest Private Limited and Suraj Finvest Private Limited remain the largest promoter entities with substantial holdings.

Major Promoter Holdings

Entity: Current Shares: Current %: Post-Transfer %:
Diwakar Finvest Private Limited: 9,87,94,786 22.63% 22.63%
Suraj Finvest Private Limited: 10,56,30,326 24.20% 24.20%
Priti A Sureka: 1,51,04,702 3.46% 3.78%
Total Promoter Holding: 23,93,93,412 54.84% 54.84%

Regulatory Compliance

The proposed transaction is being undertaken under Regulation 10(1)(a)(ii) of SEBI SAST Regulations, which provides exemption from open offer obligations for inter-se transfers among qualifying promoter entities. The promoter group has maintained compliance with disclosure requirements under Chapter V of the takeover regulations for the past three years, as evidenced by the comprehensive compliance history provided in the disclosure.

Market Impact and Rationale

The inter-se transfer represents a restructuring within the promoter group without affecting the overall promoter shareholding percentage. The transaction is structured as gifts without consideration, indicating family succession or estate planning activities within the promoter group. The 60-day volume weighted average market price of ₹512.96 per share provides the regulatory reference point for the transaction.

Historical Stock Returns for Emami

1 Day5 Days1 Month6 Months1 Year5 Years
-3.36%-4.23%-12.15%-26.76%-16.95%-8.04%

Emami Limited Showcases Strong Recovery with 11% Growth in Q3FY26

3 min read     Updated on 06 Feb 2026, 11:24 PM
scanx
Reviewed by
Radhika SScanX News Team
Overview

Emami Limited presented strong operational performance in its investor presentation, highlighting 7% domestic sales growth in FY25 and robust 11% growth in Q3FY26. The company successfully transformed its portfolio from niche to mainstream segments, with new age products increasing from 7% to 20% share. D2C brands revenue nearly doubled from FY23 to FY25, while international business maintained 11% five-year CAGR despite challenges. Key brands including Navratna, Dermicool, BoroPlus, and Zandu Healthcare delivered strong double-digit growth, supported by strategic brand rejuvenations and digital transformation initiatives.

31946081

*this image is generated using AI for illustrative purposes only.

Emami Limited presented its comprehensive investor presentation for the Nuvama India Conference 2026 and IIFL's 17th Enterprising India Global Investors' Conference, showcasing strong operational performance and strategic growth initiatives across its diversified portfolio.

Strong FY25 Performance Despite Market Challenges

The company delivered resilient performance in FY25 despite facing higher inflation and subdued rural demand. Emami demonstrated strong cost discipline and agile execution while gaining market share across key categories.

Performance Metric FY25 Growth
Domestic Net Sales (Value) +7%
Domestic Net Sales (Volume) +4%
International Net Sales (Constant Currency) +5%
International Net Sales (INR) +4%
EBIDTA +8%
Profit Before Tax +13%
Profit After Tax +11%

Key brands delivered exceptional growth with Navratna and Dermicool growing by 18%, BoroPlus expanding by 14%, and Zandu Healthcare achieving 12% growth. The company's margin expansion was driven by cost optimization and premiumization strategies, with gross margins improving by 100 basis points and EBIDTA margins expanding by 40 basis points.

Strategic Portfolio Transformation

Emami's core brands have successfully diversified from niche segments into mainstream categories. The company's new age and mainstream portfolio share increased significantly from 7% in FY20 to 20% in FY25 for domestic business.

Brand Category FY20 New Age Share FY25 New Age Share
BoroPlus 9% 23%
Kesh King 23% 41%
Smart and Handsome 13% 17%
Healthcare 4% 26%

The company has undertaken significant brand rejuvenations, including relaunching Kesh King as Kesh King Gold with new formulation and positioning, and rebranding Fair & Handsome to Smart & Handsome to expand into the grooming universe worth ₹6,700 crore.

Digital and D2C Growth Momentum

Emami's D2C brands revenue nearly doubled in FY25 compared to FY23, with gross margins improving dramatically from 47.2% in FY23 to 60.2% in FY25. The company's digital transformation includes strategic investments in startups and expansion of organized channel presence.

Channel Development FY20 FY25
Organized Channels Share 11% 29%
E-Commerce Share 0% 12%
Modern Trade Share 7% 11%

ZanduCare, the company's digital healthcare ecosystem, has shown impressive growth with approximately 100 digital-first products launched and 3.2x sales growth from FY21 to FY25. The platform has served over 21 lakh cumulative orders and achieved cumulative GMV of approximately ₹120 crore.

International Business Resilience

Despite geopolitical challenges, Emami's international business maintained steady performance with 11% five-year CAGR. The business accounts for 17% of total revenue in FY25, up from 15% in FY20. The company has strategically localized operations with 80% production and sourcing now outside India and 85% of international workforce locally hired.

Strong Q3FY26 Recovery

After facing challenges in H1FY26 due to weak summers, unseasonal rains, and GST transition impacts, Emami delivered strong 11% growth in Q3FY26. The quarter showed robust performance across the portfolio with strong growth in key brands including BoroPlus, Zandu, Mentho Plus Balm, Kesh King Gold, Navratna, Dermicool, Smart and Handsome, and The Man Company.

Quarter Performance Growth Rate Key Impact Factors
Q1FY26 0% Weak summers and unseasonal rains
Q2FY26 -10% GST transition and excess rainfall
Q3FY26 11% Strong growth across portfolio

Financial Strength and Capital Allocation

Emami maintains strong financial health with disciplined capital deployment. From FY21 to 9MFY26, the company distributed ₹2,024 crore in cumulative dividends, conducted ₹663 crore in cumulative buybacks, and invested approximately ₹985 crore in cumulative acquisitions and strategic investments. The company holds over ₹1,000 crore in net cash as of 31st December 2025, reinforcing its ability to fund growth while rewarding shareholders.

Historical Stock Returns for Emami

1 Day5 Days1 Month6 Months1 Year5 Years
-3.36%-4.23%-12.15%-26.76%-16.95%-8.04%

More News on Emami

1 Year Returns:-16.95%